Who
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Cerenome.
In numbers
- Trades disclosed
- 61
- Buys
- 9
- Sells
- 0
- Bought
- $43K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Feb 2020
- Last trade
- 1 Oct 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,533 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,165 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —287 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,443 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,443 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.